Personalized medicine is increasingly important in the administration of immunosuppressive therapy. By understanding a patient's genetic makeup, toxicologists and clinicians can predict responses to specific drugs and tailor treatments to minimize toxicity while ensuring efficacy. This personalized approach is especially beneficial in managing complex cases, such as those involving multiple immunosuppressive agents.
